Gachon University Gil Medical Center

• NCT07227428

  Collaborator, Phase 4, Not yet recruiting, 206 people, 12 Nov 2025

• NCT04014803

  Collaborator, Phase 4, Recruiting, 3,500 people, 10 Jul 2019

• NCT02439385

  Phase 2, Completed, 44 people, 8 May 2015

• NCT02232360

  Phase 4, Status unknown, 106 people, 5 Sept 2014

• NCT02152306

  Collaborator, Phase 3, Completed, 143 people, 2 Jun 2014

• NCT01926769

  Phase 2, Terminated, 2 people, 21 Aug 2013

• NCT01871792

  Phase 4, Status unknown, 404 people, 7 Jun 2013

• NCT01784120

  Phase 2, Status unknown, 48 people, 5 Feb 2013

• NCT01666067

  Phase 4, Completed, 204 people, 16 Aug 2012

• NCT01666041

  Phase 4, Completed, 120 people, 16 Aug 2012

• NCT01660919

  Phase 4, Completed, 160 people, 9 Aug 2012

• NCT01488253

  Collaborator, Phase 2, Terminated, 3 people, 8 Dec 2011

• NCT01004237

  Phase 4, Completed, 52 people, 29 Oct 2009

• NCT01003847

  Phase 4, Completed, 150 people, 29 Oct 2009

• NCT00980603

  Collaborator, Phase 2, Status unknown, 144 people, 21 Sept 2009

• NCT00915382

  Collaborator, Phase 3, Completed, 625 people, 8 Jun 2009

• NCT00745407

  Phase 4, Completed, 3 Sept 2008

• NCT00677443

  Collaborator, Phase 3, Completed, 344 people, 14 May 2008

• NCT00510107

  Phase 2, Status unknown, 90 people, 1 Aug 2007

• NCT00320294

  Phase 2, Status unknown, 86 people, 3 May 2006

• Initiation of SGLT2 Inhibitors Versus DPP-4 Inhibitors in Metformin Users and Risk of Incident Depression: A Nationwide, Claims-Based Active-Comparator New-User Study

  FRD2023-20 to Soo Jung Choi, 1 Sept 2026

Sources: pubmed.ncbi.nlm.nih.gov